MEC Practice Academy 11.19
News|Videos|August 3, 2026

How should health care pay for clinical AI? New report raises tough questions

Author(s)Todd Shryock
Fact checked by: Chris Mazzolini

A Peterson Health Technology Institute report warns that today's payment models could turn clinical AI into either a lower-cost care solution — or a new driver of health care inflation.

Clinical artificial intelligence is moving into everyday care faster than the payment systems built to support it. That mismatch is at the center of new research from the Peterson Health Technology Institute (PHTI), which asks a question the industry has largely avoided: How should health care actually pay for AI?

According to PHTI, applying today's reimbursement frameworks to AI-enabled care carries real risk. Fee-for-service could reward extra billable activity and inflate costs, while pay-for-performance and capitated models may fail to reward adoption of AI that genuinely improves outcomes. The report uses hypertension management — an area where AI-driven monitoring is already reshaping primary care — to illustrate how differently AI tools would need to be paid depending on how much clinical judgment they take on.

That distinction, between AI that assists a clinician and AI that acts more independently, turns out to matter enormously for payment design — and gets to the core of whether clinical AI ends up lowering costs or adding a new layer of reimbursement complexity.

Caroline Pearson, PHTI's executive director, spoke with Medical Economics about what the findings mean for physicians, practices and the payment models shaping the next phase of AI adoption.


Related to this article

Stroke survivors get a first-of-its-kind anticoagulant; Queens day care director admits $127M Medicare, Medicaid fraud; ovarian cancer may leave an early mark in the blood — Morning Medical Update © kwanchaichaiudom - stock.adobe.com
The top news stories in medicine today: The FDA approves the first factor XIa inhibitor to reduce the risk of a repeat stroke; a Queens adult day care program director pleads guilty in a $127 million Medicare and Medicaid fraud scheme; researchers tie a blood RNA signal to the precancerous stage of ovarian cancer.